{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":641,"n_cols":4,"rows_kept":641,"flags":["formulas_cached_only"]}
["Title","Model","SYMBOL","Coef"]
["Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma","Model-1","AURKA",{"v":0.259,"d":"0.25900"}]
[null,"Model-1","SLC7A5",{"v":0.154,"d":"0.15400"}]
[null,"Model-1","GRIA3",{"v":-1.297,"d":"-1.29700"}]
[null,"Model-1","LPIN1",{"v":-0.536,"d":"-0.53600"}]
[null,"Model-1","EGFR",{"v":0.228,"d":"0.22800"}]
[null,"Model-1","CDKN2A",{"v":-0.095,"d":"-0.09500"}]
[null,"Model-1","SLC7A11",{"v":-0.16,"d":"-0.16000"}]
[null,"Model-1","PRKAA2",{"v":0.308,"d":"0.30800"}]
[null,"Model-1","AKR1C3",{"v":0.155,"d":"0.15500"}]
[null,"Model-1"," HCAR1",{"v":-0.457,"d":"-0.45700"}]
[null,"Model-1","SOCS1",{"v":-0.208,"d":"-0.20800"}]
[null,"Model-1","ALB",{"v":0.27,"d":"0.27000"}]
["The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma","Model-2","BAK1",{"v":0.2126,"d":"0.21260"}]
[null,"Model-2","DKK1",{"v":0.137,"d":"0.13700"}]
[null,"Model-2","CDKN2A",{"v":-0.0716,"d":"-0.07160"}]
[null,"Model-2","MIF",{"v":0.2474,"d":"0.24740"}]
[null,"Model-2","MORF4L2",{"v":0.0037,"d":"0.00370"}]
[null,"Model-2","COPS2",{"v":0.0063,"d":"0.00630"}]
[null,"Model-2","USP10",{"v":0.0255,"d":"0.02550"}]
["A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma","Model-3","OLR1",{"v":0.09,"d":"0.09000"}]
[null,"Model-3","ADCY2",{"v":0.08,"d":"0.08000"}]
[null,"Model-3","LIPE",{"v":-0.15,"d":"-0.15000"}]
["A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma","Model-4","ASNS",{"v":0.308,"d":"0.30800"}]
[null,"Model-4","CYP27B1",{"v":0.228,"d":"0.22800"}]
[null,"Model-4","TXNRD1",{"v":0.284,"d":"0.28400"}]
[null,"Model-4","PLOD2",{"v":0.174,"d":"0.17400"}]
[null,"Model-4","FUT6 ",{"v":-0.092,"d":"-0.09200"}]
[null,"Model-4","HPRT1",{"v":0.362,"d":"0.36200"}]
["Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma","Model-5","TGFB1",{"v":0.011,"d":"0.01100"}]
[null,"Model-5","MMP9",{"v":0.002,"d":"0.00200"}]
[null,"Model-5","PLAU",{"v":0.002,"d":"0.00200"}]
[null,"Model-5","CTSG",{"v":-0.192,"d":"-0.19200"}]
[null,"Model-5","CCR8",{"v":-0.367,"d":"-0.36700"}]
[null,"Model-5","SEMA5B",{"v":0.61,"d":"0.61000"}]
[null,"Model-5","GAST",{"v":0.018,"d":"0.01800"}]
[null,"Model-5","OSM",{"v":0.067,"d":"0.06700"}]
[null,"Model-5","IL12RB2",{"v":-0.101,"d":"-0.10100"}]
[null,"Model-5","TNFRSF25",{"v":-0.075,"d":"-0.07500"}]
[null,"Model-5"," TNFRSF4",{"v":-0.066,"d":"-0.06600"}]
["Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma","Model-6","FN1",{"v":0.075123,"d":"0.07512"}]
[null,"Model-6","LAMB4",{"v":-0.348219,"d":"-0.34822"}]
[null,"Model-6","LAMB3",{"v":0.090359,"d":"0.09036"}]
[null,"Model-6","DMP1",{"v":0.363187,"d":"0.36319"}]
[null,"Model-6","CHAD",{"v":-0.314325,"d":"-0.31433"}]
[null,"Model-6","MMRN1",{"v":-0.125206,"d":"-0.12521"}]
["A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma","Model-7","HTN3",{"v":0.096,"d":"0.09600"}]
[null,"Model-7","CTSG",{"v":-0.152,"d":"-0.15200"}]
[null,"Model-7","MAPT",{"v":0.122,"d":"0.12200"}]
[null,"Model-7","CCL28",{"v":-0.094,"d":"-0.09400"}]
[null,"Model-7","PTX3",{"v":0.138,"d":"0.13800"}]
[null,"Model-7","SEMA3G",{"v":-0.14,"d":"-0.14000"}]
[null,"Model-7","USP2",{"v":0.107,"d":"0.10700"}]
["Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma","Model-8","SLURP1",-0.00173]
[null,"Model-8","SCARA5",-0.21582]
[null,"Model-8","CLDN10",{"v":-0.0458,"d":"-0.04580"}]
[null,"Model-8","MYH11",{"v":0.030114,"d":"0.03011"}]
[null,"Model-8","CXCL13",-0.00725]
[null,"Model-8","HLF",{"v":-0.0839,"d":"-0.08390"}]
[null,"Model-8","ITGA3",{"v":0.005721,"d":"0.00572"}]
["A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma","Model-9","PLAU ",{"v":0.0496,"d":"0.04960"}]
[null,"Model-9","STC2",{"v":0.0393,"d":"0.03930"}]
[null,"Model-9","TNFRSF4",{"v":0.0405,"d":"0.04050"}]
[null,"Model-9","PDGFA",0.00743]
[null,"Model-9","DKK1",{"v":0.0482,"d":"0.04820"}]
[null,"Model-9","CHGB ",{"v":0.0147,"d":"0.01470"}]
["8-Gene signature related to CD8+ T cell infiltration by integrating single-cell and bulk RNA-sequencing in head and neck squamous cell carcinoma","Model-10","DEFB1",{"v":-0.097,"d":"-0.09700"}]
[null,"Model-10","AICDA",{"v":-0.444,"d":"-0.44400"}]
[null,"Model-10","TYK2",{"v":-0.175,"d":"-0.17500"}]
[null,"Model-10","CCR7",{"v":-0.071,"d":"-0.07100"}]
[null,"Model-10","SCARB1",{"v":0.02,"d":"0.02000"}]
[null,"Model-10","ULBP2",{"v":0.079,"d":"0.07900"}]
[null,"Model-10","STC2",{"v":0.161,"d":"0.16100"}]
[null,"Model-10","LGR5",{"v":-0.128,"d":"-0.12800"}]
["A Novel Inflammatory Response–Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma","Model-11","CCL22 ",{"v":-0.184,"d":"-0.18400"}]
[null,"Model-11","CCR7",{"v":-0.386,"d":"-0.38600"}]
[null,"Model-11","CD48",{"v":0.649,"d":"0.64900"}]
[null,"Model-11","F3",{"v":0.083,"d":"0.08300"}]
[null,"Model-11","HBEGF",{"v":0.322,"d":"0.32200"}]
[null,"Model-11","IL10",{"v":1.055,"d":"1.05500"}]
[null,"Model-11","IL10RA",{"v":-0.474,"d":"-0.47400"}]
[null,"Model-11","IL2RB",{"v":0.479,"d":"0.47900"}]
[null,"Model-11","LCK",{"v":-0.392,"d":"-0.39200"}]
[null,"Model-11","PIK3R5",{"v":1.014,"d":"1.01400"}]
[null,"Model-11","PSEN1",{"v":0.57,"d":"0.57000"}]
[null,"Model-11","TIMP1",{"v":0.223,"d":"0.22300"}]
[null,"Model-11","TNFAIP6",{"v":0.215,"d":"0.21500"}]
[null,"Model-11","TNFRSF1B",{"v":-0.442,"d":"-0.44200"}]
["An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma","Model-12","CAT",{"v":0.1407,"d":"0.14070"}]
[null,"Model-12","MTFR1L",{"v":-0.0002,"d":"-0.00020"}]
[null,"Model-12","OXA1L",{"v":0.0179,"d":"0.01790"}]
[null,"Model-12","POLE",{"v":-0.2615,"d":"-0.26150"}]
[null,"Model-12","NTHL1",{"v":-0.0043,"d":"-0.00430"}]
[null,"Model-12","DNA2",{"v":-0.0667,"d":"-0.06670"}]
[null,"Model-12","ATP7B",{"v":0.0628,"d":"0.06280"}]
[null,"Model-12","ISCA2",{"v":0.1622,"d":"0.16220"}]
[null,"Model-12","GLRX5",{"v":0.089,"d":"0.08900"}]
[null,"Model-12","NDUFA1",{"v":-0.0733,"d":"-0.07330"}]
[null,"Model-12","NDUFB2",{"v":-0.0589,"d":"-0.05890"}]
[null,"Model-12","DLAT",{"v":-0.0045,"d":"-0.00450"}]
["Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma","Model-13","CBX3",{"v":0.004293,"d":"0.00429"}]
[null,"Model-13","GNA12",{"v":0.001124,"d":"0.00112"}]
[null,"Model-13","P4HA1",{"v":0.0145,"d":"0.01450"}]
[null,"Model-13","PLAU",{"v":0.001283,"d":"0.00128"}]
[null,"Model-13","PPL",{"v":0.001023,"d":"0.00102"}]
[null,"Model-13","RAB25",{"v":0.001824,"d":"0.00182"}]
[null,"Model-13","EPHX3",0.01243]
[null,"Model-13","HLF",{"v":-0.0255,"d":"-0.02550"}]
["Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration","Model-14","CCL13",{"v":0.038,"d":"0.03800"}]
[null,"Model-14","CCR7",{"v":-0.1049,"d":"-0.10490"}]
[null,"Model-14","CD276",{"v":0.0073,"d":"0.00730"}]
[null,"Model-14","IL1B",{"v":0.0034,"d":"0.00340"}]
[null,"Model-14","LYVE1",{"v":0.0673,"d":"0.06730"}]
[null,"Model-14","VEGFC",{"v":0.002,"d":"0.00200"}]
["Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma","Model-15","UGT1A1",{"v":0.112,"d":"0.11200"}]
[null,"Model-15","SULT1B1",{"v":-0.129,"d":"-0.12900"}]
[null,"Model-15","SOD1",{"v":0.223,"d":"0.22300"}]
[null,"Model-15","SLCO1B3",{"v":0.062,"d":"0.06200"}]
[null,"Model-15","SLCO1B1",{"v":0.617,"d":"0.61700"}]
[null,"Model-15","PPARG",{"v":0.138,"d":"0.13800"}]
[null,"Model-15","CYP8B1",{"v":-1.328,"d":"-1.32800"}]
[null,"Model-15","CYP7B1",{"v":-0.042,"d":"-0.04200"}]
[null,"Model-15","CYP4F12",{"v":0.052,"d":"0.05200"}]
[null,"Model-15","CYP2D6",{"v":-0.898,"d":"-0.89800"}]
[null,"Model-15","ALDH2",{"v":-0.009,"d":"-0.00900"}]
[null,"Model-15","ABCB8",{"v":-0.076,"d":"-0.07600"}]
[null,"Model-15","ABCB4",{"v":-0.278,"d":"-0.27800"}]
[null,"Model-15","ABCB1",{"v":-0.507,"d":"-0.50700"}]
["A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma","Model-16","DAD1",{"v":2.316,"d":"2.31600"}]
[null,"Model-16","CYCS",{"v":1.426,"d":"1.42600"}]
[null,"Model-16","CSNK2A2",{"v":1.576,"d":"1.57600"}]
[null,"Model-16","VPS25",{"v":0.728,"d":"0.72800"}]
[null,"Model-16","VDAC1",{"v":0.976,"d":"0.97600"}]
[null,"Model-16","TMLHE",{"v":0.381,"d":"0.38100"}]
[null,"Model-16","CYTH3",{"v":0.024,"d":"0.02400"}]
[null,"Model-16","PRKCA",{"v":0.26,"d":"0.26000"}]
[null,"Model-16","TP73",{"v":-0.567,"d":"-0.56700"}]
[null,"Model-16","FZD6",{"v":0.047,"d":"0.04700"}]
[null,"Model-16","SQSTM1",{"v":0.094,"d":"0.09400"}]
[null,"Model-16","MAP2K7",{"v":-3.07,"d":"-3.07000"}]
["Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma","Model-17","CXCL1",{"v":0.0038,"d":"0.00380"}]
[null,"Model-17","CHGB",{"v":0.0037,"d":"0.00370"}]
[null,"Model-17","NR4A1",{"v":0.0029,"d":"0.00290"}]
[null,"Model-17","ELANE",{"v":0.0387,"d":"0.03870"}]
[null,"Model-17","PTX3",{"v":0.0037,"d":"0.00370"}]
[null,"Model-17","CD79A",{"v":-0.0082,"d":"-0.00820"}]
[null,"Model-17","TNFRSF17",{"v":0.0022,"d":"0.00220"}]
["An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance","Model-18","ANO1",{"v":0.0418,"d":"0.04180"}]
[null,"Model-18","AQP1",{"v":-0.2274,"d":"-0.22740"}]
[null,"Model-18","AQP5",{"v":-0.071,"d":"-0.07100"}]
[null,"Model-18","AQP9",{"v":0.113,"d":"0.11300"}]
[null,"Model-18","BEST2",{"v":-0.3912,"d":"-0.39120"}]
[null,"Model-18","CHRNA5",{"v":0.1945,"d":"0.19450"}]
[null,"Model-18","KCNJ15",{"v":0.0751,"d":"0.07510"}]
[null,"Model-18","KCNG1",{"v":0.1902,"d":"0.19020"}]
[null,"Model-18","SCNN1G",{"v":-0.0261,"d":"-0.02610"}]
[null,"Model-18","SCN4A",{"v":0.2879,"d":"0.28790"}]
[null,"Model-18","TRPC1",{"v":0.1546,"d":"0.15460"}]
[null,"Model-18","VDAC1",{"v":0.24,"d":"0.24000"}]
["Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity","Model-19","ADA",{"v":0.2527,"d":"0.25270"}]
[null,"Model-19","CYP2D6",{"v":-0.668,"d":"-0.66800"}]
[null,"Model-19","RYR2",{"v":0.3155,"d":"0.31550"}]
[null,"Model-19","DSCAM",{"v":0.3035,"d":"0.30350"}]
[null,"Model-19","IRF4",{"v":-0.1897,"d":"-0.18970"}]
[null,"Model-19","HPRT1",{"v":0.5259,"d":"0.52590"}]
["Mast cell marker gene signature in head and neck squamous cell carcinoma","Model-20","KIT",{"v":-0.0355,"d":"-0.03550"}]
[null,"Model-20"," RAB32",{"v":0.0018,"d":"0.00180"}]
[null,"Model-20","CATSPER1",{"v":0.1094,"d":"0.10940"}]
[null,"Model-20","SMYD3","0.0233 "]
[null,"Model-20"," LINC00996",{"v":-0.4625,"d":"-0.46250"}]
[null,"Model-20"," SOCS1",{"v":-0.0168,"d":"-0.01680"}]
[null,"Model-20","AP2M1","0.0007 "]
[null,"Model-20","LAT",{"v":-0.7264,"d":"-0.72640"}]
[null,"Model-20"," HSP90B1",{"v":0.0015,"d":"0.00150"}]
["HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma","Model-21","CDKN2A",{"v":-0.0413836017920187,"d":"-0.04138"}]
[null,"Model-21","CELSR3",{"v":-0.365345241419471,"d":"-0.36535"}]
[null,"Model-21","DMRTA2",{"v":-0.0633132503419892,"d":"-0.06331"}]
[null,"Model-21","SERPINE1",{"v":0.0162329920245241,"d":"0.01623"}]
[null,"Model-21","TJP3",-0.04689]
[null,"Model-21","FADD",{"v":0.128745,"d":"0.12875"}]
[null,"Model-21","IGF2BP2",{"v":0.139702586686539,"d":"0.13970"}]
["Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction","Model-22","FLT3",{"v":-0.0966956,"d":"-0.09670"}]
[null,"Model-22","IL6",{"v":0.0873983,"d":"0.08740"}]
[null,"Model-22","KEAP1",{"v":0.4095449,"d":"0.40954"}]
[null,"Model-22","NQO1",{"v":0.1254306,"d":"0.12543"}]
[null,"Model-22","SOCS1",{"v":0.1389582,"d":"0.13896"}]
[null,"Model-22","TRIB3",{"v":0.1288005,"d":"0.12880"}]
["Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma","Model-23","SSB",{"v":1.236,"d":"1.23600"}]
[null,"Model-23","PFKP",{"v":0.628,"d":"0.62800"}]
[null,"Model-23","NAT10",{"v":0.567,"d":"0.56700"}]
[null,"Model-23","PCDH9",{"v":0.498,"d":"0.49800"}]
[null,"Model-23","SHANK2",{"v":0.189,"d":"0.18900"}]
[null,"Model-23","PAX8",{"v":-0.443,"d":"-0.44300"}]
[null,"Model-23","CELSR3",{"v":-0.529,"d":"-0.52900"}]
[null,"Model-23","DCLRE1C",{"v":-0.806,"d":"-0.80600"}]
[null,"Model-23","MAP2K7",{"v":-1.865,"d":"-1.86500"}]
[null,"Model-23","ODF4",{"v":-2.439,"d":"-2.43900"}]
["Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma","Model-24","P2RY8",{"v":0.490331935,"d":"0.49033"}]
[null,"Model-24","FLT3LG",{"v":-0.363760832,"d":"-0.36376"}]
[null,"Model-24","GIMAP1",{"v":0.387873078,"d":"0.38787"}]
[null,"Model-24","CD79A",{"v":-0.168052271,"d":"-0.16805"}]
[null,"Model-24","SLAMF6",{"v":0.368179613,"d":"0.36818"}]
[null,"Model-24","FGD3",{"v":-0.238932879,"d":"-0.23893"}]
[null,"Model-24","IKZF3",{"v":0.193711011,"d":"0.19371"}]
[null,"Model-24","FAM107A",{"v":-0.263580347,"d":"-0.26358"}]
[null,"Model-24","MAP4K1",{"v":0.373764051,"d":"0.37376"}]
[null,"Model-24","GZMM",{"v":-0.223385774,"d":"-0.22339"}]
[null,"Model-24","CCR7",{"v":-0.508653299,"d":"-0.50865"}]
[null,"Model-24","P2RY10",{"v":0.321200005,"d":"0.32120"}]
[null,"Model-24","XCR1",{"v":-0.277393854,"d":"-0.27739"}]
[null,"Model-24","NLRC3",{"v":-0.374350099,"d":"-0.37435"}]
[null,"Model-24","UBASH3A",{"v":-0.454714574,"d":"-0.45471"}]
[null,"Model-24","ABCB1",{"v":-0.45779747,"d":"-0.45780"}]
["A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study","Model-25","CTSG",{"v":-0.235852555481698,"d":"-0.23585"}]
[null,"Model-25","TNFRSF4",{"v":-0.127188255049261,"d":"-0.12719"}]
[null,"Model-25","IGLV1-44",{"v":-0.0157820710202927,"d":"-0.01578"}]
[null,"Model-25","STC2",{"v":0.0909125160196324,"d":"0.09091"}]
[null,"Model-25"," CCL22",{"v":-0.0661762958246814,"d":"-0.06618"}]
["An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma","Model-26","CXCR3",{"v":-0.0748,"d":"-0.07480"}]
[null,"Model-26","PDIA3",{"v":0.1722,"d":"0.17220"}]
[null,"Model-26","HSP90AA1",{"v":0.0945,"d":"0.09450"}]
[null,"Model-26","NT5E",{"v":0.0806,"d":"0.08060"}]
[null,"Model-26","ATG5",{"v":0.1971,"d":"0.19710"}]
[null,"Model-26","PRF1",{"v":-0.1156,"d":"-0.11560"}]
[null,"Model-26","IL17A",{"v":-0.325,"d":"-0.32500"}]
[null,"Model-26","IL10 ",{"v":-0.3283,"d":"-0.32830"}]
[null,"Model-26","IL6",{"v":0.0937,"d":"0.09370"}]
[null,"Model-26","CD8B",{"v":0.1397,"d":"0.13970"}]
[null,"Model-26","CD4",{"v":0.0909,"d":"0.09090"}]
[null,"Model-26","ENTPD1",{"v":-0.1915,"d":"-0.19150"}]
["A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration","Model-27","MTDH",{"v":0.547,"d":"0.54700"}]
[null,"Model-27","BAK1",{"v":0.496,"d":"0.49600"}]
[null,"Model-27","PRDX4",{"v":0.422,"d":"0.42200"}]
[null,"Model-27","IKZF3",{"v":0.368,"d":"0.36800"}]
[null,"Model-27","FN1",{"v":0.326,"d":"0.32600"}]
[null,"Model-27","ERBB2",{"v":0.45,"d":"0.45000"}]
[null,"Model-27","LTF",{"v":0.157,"d":"0.15700"}]
["Signature Based on Six Autophagy-related Genes to Predict Prognosis of Head and Neck Squamous Cell Carcinoma","Model-28","GABARAPL2",{"v":0.1459482,"d":"0.14595"}]
[null,"Model-28","SAR1A",{"v":0.1549568,"d":"0.15496"}]
[null,"Model-28","ST13",{"v":0.1554117,"d":"0.15541"}]
[null,"Model-28","GAPDH",{"v":0.1892597,"d":"0.18926"}]
[null,"Model-28","FADD",{"v":0.1121593,"d":"0.11216"}]
[null,"Model-28","LAMP1",{"v":0.0857282,"d":"0.08573"}]
["Identification of a metabolic reprogramming‐related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis","Model-29","PIP5K1B",{"v":0.033363,"d":"0.03336"}]
[null,"Model-29","ADA",{"v":0.024469,"d":"0.02447"}]
[null,"Model-29","KYNU",{"v":0.013974,"d":"0.01397"}]
[null,"Model-29","P4HA1",{"v":0.012453,"d":"0.01245"}]
[null,"Model-29","MTHFD2",{"v":0.010309,"d":"0.01031"}]
[null,"Model-29","HPRT1 ",{"v":0.010282,"d":"0.01028"}]
[null,"Model-29","ALG3",{"v":0.005389,"d":"0.00539"}]
[null,"Model-29","PYGL",{"v":0.004299,"d":"0.00430"}]
[null,"Model-29","DNMT1",{"v":-0.014064,"d":"-0.01406"}]
[null,"Model-29","POLE2",{"v":-0.077976,"d":"-0.07798"}]
[null,"Model-29","PDE6G",{"v":-0.081091,"d":"-0.08109"}]
[null,"Model-29","CYP2D6",-0.16025]
["Construction of a hypoxia-derived gene model to predict the prognosis and therapeutic response of head and neck squamous cell carcinoma","Model-30","THBS1",{"v":0.125,"d":"0.12500"}]
[null,"Model-30","RNASE7",{"v":0.151,"d":"0.15100"}]
[null,"Model-30","DKK1",{"v":0.076,"d":"0.07600"}]
[null,"Model-30","SPINK6",{"v":-0.187,"d":"-0.18700"}]
[null,"Model-30","HOXC13",{"v":0.206,"d":"0.20600"}]
[null,"Model-30","TNFRSF4 ",{"v":-0.213,"d":"-0.21300"}]
[null,"Model-30","CCL22",{"v":-0.128,"d":"-0.12800"}]
["Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma","Model-31","YTHDC2",{"v":-0.176,"d":"-0.17600"}]
[null,"Model-31","HNRNPC",{"v":0.013,"d":"0.01300"}]
["A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival","Model-32","AATF",{"v":0.198,"d":"0.19800"}]
[null,"Model-32","APP",{"v":0.244,"d":"0.24400"}]
[null,"Model-32","GNPDA1",{"v":0.252,"d":"0.25200"}]
[null,"Model-32","HPRT1",{"v":0.314,"d":"0.31400"}]
[null,"Model-32","LASP1",{"v":0.136,"d":"0.13600"}]
[null,"Model-32","P4HA1",{"v":0.11,"d":"0.11000"}]
[null,"Model-32","ILF3",{"v":-0.388,"d":"-0.38800"}]
["Acircadian rhythm-related gene signature for predicting survival and drug response in HNSC","Model-33","PER2",{"v":-0.2371,"d":"-0.23710"}]
[null,"Model-33","PER3 ",{"v":-0.0807,"d":"-0.08070"}]
[null,"Model-33","GHRL",{"v":-0.2003,"d":"-0.20030"}]
[null,"Model-33","CSF2",{"v":0.0277,"d":"0.02770"}]
[null,"Model-33","HDAC3",{"v":0.5065,"d":"0.50650"}]
[null,"Model-33","KLF10",{"v":0.1196,"d":"0.11960"}]
[null,"Model-33","PRKAA2 ",{"v":0.2072,"d":"0.20720"}]
[null,"Model-33","PTGDS",{"v":-0.0698,"d":"-0.06980"}]
[null,"Model-33","RORB",{"v":-0.1509,"d":"-0.15090"}]
["A Novel Signature of Necroptosis-Associated Genes as a Potential Prognostic Tool for Head and Neck Squamous Cell Carcinoma","Model-34","FADD",{"v":0.0037,"d":"0.00370"}]
[null,"Model-34","AXL ",{"v":0.0131,"d":"0.01310"}]
[null,"Model-34","CDKN2A",{"v":-0.0105,"d":"-0.01050"}]
[null,"Model-34","HSP90AA1",{"v":0.0009,"d":"0.00090"}]
[null,"Model-34","BNIP3",{"v":0.0201,"d":"0.02010"}]
[null,"Model-34","APP",{"v":0.0009,"d":"0.00090"}]
["Development of a novel prognostic signature derived from essential genes in head and neck squamous cell carcinoma","Model-35","PSMD2",0.09239]
[null,"Model-35","TXNRD1 ",0.10146]
[null,"Model-35"," SLC7A5",0.00219]
[null,"Model-35","CDK6"," 0.01787 "]
[null,"Model-35"," AP2M1",0.06351]
[null,"Model-35","EGFR","0.06757 "]
[null,"Model-35","AURKA",0.03545]
[null,"Model-35","PLK1",0.25567]
["A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma","Model-36","BATF2",{"v":-0.147,"d":"-0.14700"}]
[null,"Model-36","CTLA4",{"v":-0.135,"d":"-0.13500"}]
[null,"Model-36","EGFR",{"v":0.283,"d":"0.28300"}]
[null,"Model-36","HLA-DQB1",{"v":-0.168,"d":"-0.16800"}]
[null,"Model-36","IKBKG",{"v":-0.56,"d":"-0.56000"}]
[null,"Model-36","PIK3R2",{"v":0.773,"d":"0.77300"}]
[null,"Model-36","PPP3CA",{"v":-0.399,"d":"-0.39900"}]
["Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma","Model-37"," HPRT1",{"v":0.019464,"d":"0.01946"}]
[null,"Model-37"," STC2",{"v":0.0261,"d":"0.02610"}]
[null,"Model-37","PLCB3",{"v":0.012804,"d":"0.01280"}]
[null,"Model-37","GPR87",{"v":0.005647,"d":"0.00565"}]
[null,"Model-37"," PYGL ",{"v":0.005313,"d":"0.00531"}]
[null,"Model-37","SLC5A12",{"v":0.384181,"d":"0.38418"}]
["Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis","Model-38","MYO1H",{"v":-0.757,"d":"-0.75700"}]
[null,"Model-38","TNFRSF13B",{"v":-0.31,"d":"-0.31000"}]
[null,"Model-38","GNG8",{"v":-0.235,"d":"-0.23500"}]
[null,"Model-38","FOXA2",{"v":0.133,"d":"0.13300"}]
[null,"Model-38","METTL7B",{"v":0.117,"d":"0.11700"}]
[null,"Model-38","SYT14",{"v":0.186,"d":"0.18600"}]
["Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma","Model-39","MAGEB2",{"v":0.0864,"d":"0.08640"}]
[null,"Model-39","SUSD1",{"v":0.4621,"d":"0.46210"}]
[null,"Model-39","ZNF382",{"v":-0.215,"d":"-0.21500"}]
[null,"Model-39","ZNF418",{"v":-0.0929,"d":"-0.09290"}]
[null,"Model-39","ZNF732",{"v":-0.0817,"d":"-0.08170"}]
["Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC","Model-40","PPIB",0.19805]
[null,"Model-40","BASP1",0.09904]
[null,"Model-40","PLOD2",0.15977]
[null,"Model-40","WIPF1",-0.23734]
["Comprehensive Analysis of mTORC1 Signaling Pathway–Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy","Model-41","SEC11A",{"v":0.44,"d":"0.44000"}]
[null,"Model-41","CYB5B",{"v":0.28,"d":"0.28000"}]
[null,"Model-41","HPRT1",{"v":0.273,"d":"0.27300"}]
[null,"Model-41","SLC2A3",{"v":0.232,"d":"0.23200"}]
[null,"Model-41","SC5D",{"v":0.214,"d":"0.21400"}]
[null,"Model-41","CORO1A",{"v":-0.124,"d":"-0.12400"}]
[null,"Model-41","PIK3R3",{"v":-0.231,"d":"-0.23100"}]
["Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma","Model-42","SYT17",0.18296]
[null,"Model-42","TNFRSF19",-0.18569]
[null,"Model-42","FGD3",{"v":-0.2889,"d":"-0.28890"}]
["Ferroptosis-related genes for predicting prognosis of patients with laryngeal squamous cell carcinoma","Model-43","FTH1",{"v":0.001,"d":"0.00100"}]
[null,"Model-43","PHKG2",{"v":-0.243,"d":"-0.24300"}]
[null,"Model-43","TFRC",{"v":-0.058,"d":"-0.05800"}]
["Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma","Model-44","PLAU",{"v":0.002,"d":"0.00200"}]
[null,"Model-44","CLDN8",{"v":0.048,"d":"0.04800"}]
[null,"Model-44","CDKN2A",{"v":-0.012,"d":"-0.01200"}]
["Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC ","Model-45","SPOCK1",0.17346]
[null,"Model-45","BOC",-0.29808]
[null,"Model-45","KNSTRN",0.26439]
[null,"Model-45","MME",{"v":0.1858,"d":"0.18580"}]
[null,"Model-45","GRIA3",-0.15037]
["A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma","Model-46","GPT",{"v":-1.922494852,"d":"-1.92249"}]
[null,"Model-46","SMS",{"v":0.772558166,"d":"0.77256"}]
["Glycolysis related gene expression signature in predicting prognosis of laryngeal squamous cell carcinoma","Model-47","PLOD2",{"v":0.7058,"d":"0.70580"}]
[null,"Model-47","DDIT4",{"v":-0.5438,"d":"-0.54380"}]
["Transcriptomic signature associated with RNA-binding proteins for survival stratification of laryngeal cancer","Model-48","GTPBP3",{"v":-2.421,"d":"-2.42100"}]
[null,"Model-48","KHDRBS3",{"v":2.022,"d":"2.02200"}]
[null,"Model-48","RBM38",{"v":-1.071,"d":"-1.07100"}]
["Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis","Model-49","SCG3",{"v":0.369,"d":"0.36900"}]
[null,"Model-49","SYP",{"v":0.296,"d":"0.29600"}]
[null,"Model-49","RUNDC3A",{"v":0.128,"d":"0.12800"}]
[null,"Model-49","CDK5R2",{"v":-0.073,"d":"-0.07300"}]
[null,"Model-49","AP3B2",{"v":0.115,"d":"0.11500"}]
["Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer","Model-50","RCN1",{"v":0.656925,"d":"0.65693"}]
[null,"Model-50","LAT2",-0.64264]
[null,"Model-50","DAPK2",-0.26934]
[null,"Model-50","DNAJA2",{"v":0.380614,"d":"0.38061"}]
[null,"Model-50","FUZ",-0.28219]
[null,"Model-50","LASP1",{"v":0.709185,"d":"0.70919"}]
[null,"Model-50","IBSP",{"v":0.412168,"d":"0.41217"}]
[null,"Model-50","HOOK2",-0.77876]
["Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma","Model-51","CASP1","0.197 "]
[null,"Model-51","GSDME",{"v":0.145,"d":"0.14500"}]
[null,"Model-51","IL6",{"v":0.096,"d":"0.09600"}]
[null,"Model-51","NLRP1",{"v":-0.392,"d":"-0.39200"}]
[null,"Model-51","NLRP2","0.116 "]
[null,"Model-51","NLRP6",{"v":1.359,"d":"1.35900"}]
[null,"Model-51","NOD2",{"v":-0.237,"d":"-0.23700"}]
["A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma","Model-52","NLRP1",{"v":0.8938,"d":"0.89380"}]
[null,"Model-52","GSDME",{"v":1.0402,"d":"1.04020"}]
[null,"Model-52","NLRP6",{"v":0.4383,"d":"0.43830"}]
[null,"Model-52","IL1B",{"v":1.0041,"d":"1.00410"}]
["A novel pyroptosis-related gene signature for predicting laryngeal carcinoma prognosis","Model-53","CHMP7",{"v":-0.1703,"d":"-0.17030"}]
[null,"Model-53","GSDME",{"v":0.1658,"d":"0.16580"}]
[null,"Model-53","GZMB",{"v":-0.1247,"d":"-0.12470"}]
[null,"Model-53","CASP9",{"v":-0.0193,"d":"-0.01930"}]
[null,"Model-53","IL6",{"v":0.0689,"d":"0.06890"}]
[null,"Model-53","NLRP1",{"v":-0.2006,"d":"-0.20060"}]
["Identification of pyroptosis-related clusters for prediction of overall survival and characterization of tumor microenvironment infiltration in laryngeal squamous cell carcinoma","Model-54","BATF",{"v":-0.465,"d":"-0.46500"}]
[null,"Model-54","PLAU",{"v":0.2803,"d":"0.28030"}]
[null,"Model-54","MST1R",{"v":-0.3443,"d":"-0.34430"}]
["A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma","Model-55","DEFB1",{"v":-0.319322778,"d":"-0.31932"}]
[null,"Model-55","EDNRB",{"v":-0.417843642,"d":"-0.41784"}]
[null,"Model-55","ADM",{"v":0.24520493,"d":"0.24520"}]
[null,"Model-55","BTC",{"v":0.709588827,"d":"0.70959"}]
[null,"Model-55","DKK1",{"v":0.477760262,"d":"0.47776"}]
[null,"Model-55","FAM3D",{"v":-0.25962002,"d":"-0.25962"}]
[null,"Model-55","GNRH1",{"v":-0.453322755,"d":"-0.45332"}]
[null,"Model-55","STC2",{"v":0.416649823,"d":"0.41665"}]
[null,"Model-55","TNFRSF12A",{"v":0.2610282,"d":"0.26103"}]
[null,"Model-55","CTLA4",{"v":-0.357569677,"d":"-0.35757"}]
["Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma","Model-56","D2HGDH",{"v":0.3929517,"d":"0.39295"}]
[null,"Model-56","PEX11A",{"v":0.3627132,"d":"0.36271"}]
[null,"Model-56","NLRP2",{"v":0.3038125,"d":"0.30381"}]
[null,"Model-56","SERP1NE1",{"v":0.275704,"d":"0.27570"}]
[null,"Model-56","UPK2",{"v":0.188539,"d":"0.18854"}]
[null,"Model-56","CTTN",{"v":0.1112888,"d":"0.11129"}]
["A cuproptosis and copper metabolism–related gene prognostic index for head and neck squamous cell carcinoma","Model-57","CYP2D6",{"v":-0.3847,"d":"-0.38470"}]
[null,"Model-57","PRKN",{"v":0.1679,"d":"0.16790"}]
[null,"Model-57","ABCB1",{"v":-0.2781,"d":"-0.27810"}]
[null,"Model-57","CCL5",{"v":-0.0177,"d":"-0.01770"}]
[null,"Model-57","LOXL1",{"v":-0.0066,"d":"-0.00660"}]
[null,"Model-57","MT1E",{"v":0.0252,"d":"0.02520"}]
[null,"Model-57","CDKN2A",{"v":-0.0554,"d":"-0.05540"}]
[null,"Model-57","CXCL8",{"v":0.15,"d":"0.15000"}]
[null,"Model-57","COX11",{"v":0.3308,"d":"0.33080"}]
[null,"Model-57","COX5A",{"v":0.0942,"d":"0.09420"}]
[null,"Model-57","COX19",{"v":0.0945,"d":"0.09450"}]
[null,"Model-57","ACLY",{"v":0.0222,"d":"0.02220"}]
[null,"Model-57","BCL2",{"v":-0.0005,"d":"-0.00050"}]
[null,"Model-57","DAPK2",{"v":-0.0047,"d":"-0.00470"}]
["Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC","Model-58","KIR3DL2",{"v":-0.369,"d":"-0.36900"}]
[null,"Model-58","MAP2K1",{"v":0.207,"d":"0.20700"}]
[null,"Model-58","CSF2",{"v":0.026,"d":"0.02600"}]
[null,"Model-58","ZAP70",{"v":0.177,"d":"0.17700"}]
[null,"Model-58","SH3BP2",{"v":-0.286,"d":"-0.28600"}]
[null,"Model-58","PIK3R2",{"v":-1.02,"d":"-1.02000"}]
[null,"Model-58","ULBP1",{"v":0.122,"d":"0.12200"}]
[null,"Model-58","KLRK1",{"v":-0.395,"d":"-0.39500"}]
[null,"Model-58","PRKCA ",{"v":0.113,"d":"0.11300"}]
[null,"Model-58","FASLG",{"v":0.294,"d":"0.29400"}]
[null,"Model-58","BID ",{"v":0.15,"d":"0.15000"}]
[null,"Model-58","LAMP1",{"v":0.07,"d":"0.07000"}]
[null,"Model-58","SLAMF7",{"v":0.009,"d":"0.00900"}]
[null,"Model-58","PVR",{"v":0.081,"d":"0.08100"}]
[null,"Model-58","PGM3",{"v":0.013,"d":"0.01300"}]
[null,"Model-58","RAG1",{"v":0.086,"d":"0.08600"}]
[null,"Model-58","WIPF1",{"v":-0.187,"d":"-0.18700"}]
["Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma","Model-59","MAP1LC3A",{"v":-0.191,"d":"-0.19100"}]
[null,"Model-59","SLC7A5",{"v":0.189,"d":"0.18900"}]
[null,"Model-59","OTUB1",{"v":0.525,"d":"0.52500"}]
[null,"Model-59","PRDX6",{"v":0.399,"d":"0.39900"}]
[null,"Model-59","MAP3K5",{"v":-0.374,"d":"-0.37400"}]
[null,"Model-59","SOCS1",{"v":-0.258,"d":"-0.25800"}]
[null,"Model-59","ATG5",{"v":0.555,"d":"0.55500"}]
[null,"Model-59","DDIT4",{"v":0.227,"d":"0.22700"}]
[null,"Model-59","ACSL3",{"v":0.406,"d":"0.40600"}]
[null,"Model-59","PRKAA2",{"v":0.602,"d":"0.60200"}]
["A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma","Model-60","KDELC1",{"v":0.043622,"d":"0.04362"}]
[null,"Model-60","ALG3",{"v":0.009262,"d":"0.00926"}]
[null,"Model-60","PYGL",0.00617]
[null,"Model-60","EXT2",{"v":0.003267,"d":"0.00327"}]
[null,"Model-60","FUT2",0.00738]
["The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma","Model-61","MORF4L2",{"v":0.0037,"d":"0.00370"}]
[null,"Model-61","COPS2",{"v":0.0063,"d":"0.00630"}]
[null,"Model-61","USP10",{"v":0.0255,"d":"0.02550"}]
[null,"Model-61","WAS",{"v":-0.0123,"d":"-0.01230"}]
[null,"Model-61","UVSSA",{"v":-0.1324,"d":"-0.13240"}]
[null,"Model-61","PRRX1",{"v":-0.0148,"d":"-0.01480"}]
[null,"Model-61","ZBTB1",{"v":-0.0632,"d":"-0.06320"}]
[null,"Model-61","DCLRE1C",{"v":-0.0502,"d":"-0.05020"}]
[null,"Model-61","MSH5",{"v":-0.3824,"d":"-0.38240"}]
[null,"Model-61","DOT1L",{"v":-0.1573,"d":"-0.15730"}]
[null,"Model-61","ZBTB7A",{"v":-0.0061,"d":"-0.00610"}]
[null,"Model-61","POLR2C",{"v":0.0085,"d":"0.00850"}]
[null,"Model-61","MORF4L1",{"v":0.0047,"d":"0.00470"}]
["A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma","Model-62","HPRT1",{"v":0.57,"d":"0.57000"}]
[null,"Model-62","AGPAT4",{"v":0.24,"d":"0.24000"}]
[null,"Model-62","AMY2B",{"v":-0.5,"d":"-0.50000"}]
[null,"Model-62","ACADL",{"v":0.59,"d":"0.59000"}]
[null,"Model-62","CKM",{"v":0.07,"d":"0.07000"}]
[null,"Model-62","PLA2G2D",{"v":-0.21,"d":"-0.21000"}]
[null,"Model-62","ADA",{"v":0.21,"d":"0.21000"}]
["Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma","Model-63","EEF2K",{"v":-0.29,"d":"-0.29000"}]
[null,"Model-63","LAMP1",{"v":0.187,"d":"0.18700"}]
[null,"Model-63","GABARAPL2",{"v":0.317,"d":"0.31700"}]
[null,"Model-63","MAP1LC3A",{"v":-0.239,"d":"-0.23900"}]
[null,"Model-63","WIPI2",{"v":0.59,"d":"0.59000"}]
[null,"Model-63","IKBKB",{"v":-0.309,"d":"-0.30900"}]
[null,"Model-63","ST13",{"v":0.38,"d":"0.38000"}]
[null,"Model-63","NAMPT",{"v":0.123,"d":"0.12300"}]
[null,"Model-63","MAP2K7",{"v":-0.575,"d":"-0.57500"}]
[null,"Model-63","GAPDH",{"v":0.27,"d":"0.27000"}]
[null,"Model-63","ATIC",{"v":0.248,"d":"0.24800"}]
[null,"Model-63","VAMP7",{"v":0.37,"d":"0.37000"}]
[null,"Model-63","SAR1A",{"v":0.493,"d":"0.49300"}]
[null,"Model-63","NKX2-3",{"v":-0.278,"d":"-0.27800"}]
[null,"Model-63","TSC2",{"v":0.307,"d":"0.30700"}]
["Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma","Model-64","ADGRE1",{"v":0.283652,"d":"0.28365"}]
[null,"Model-64","OLR1",{"v":0.146693,"d":"0.14669"}]
[null,"Model-64","GPR132 ",{"v":-0.292147,"d":"-0.29215"}]
[null,"Model-64","TIMP1",{"v":0.156694,"d":"0.15669"}]
[null,"Model-64","CCR7",{"v":-0.327125,"d":"-0.32713"}]
[null,"Model-64","PSEN1",{"v":0.401136,"d":"0.40114"}]
[null,"Model-64","NAMPT",{"v":0.127155,"d":"0.12716"}]
["Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell","Model-65","EIF2S1",{"v":0.16,"d":"0.16000"}]
[null,"Model-65","Keap1",{"v":-0.153,"d":"-0.15300"}]
[null,"Model-65","MAP3K5",{"v":-0.177,"d":"-0.17700"}]
[null,"Model-65","SLC2A3",{"v":0.066,"d":"0.06600"}]
[null,"Model-65","FTH1",{"v":0.236,"d":"0.23600"}]
[null,"Model-65","SELENOS",{"v":0.068,"d":"0.06800"}]
[null,"Model-65","CDKN2A",{"v":-0.153,"d":"-0.15300"}]
["A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer","Model-66","NFE2L2",{"v":2e-05,"d":"0.00002"}]
[null,"Model-66","ATP7B","0.19544 "]
[null,"Model-66","SLC31A1",{"v":0.0145,"d":"0.01450"}]
[null,"Model-66","FDX1",0.05154]
[null,"Model-66","DLAT",0.00013]
[null,"Model-66","PDHA1","0.01425 "]
[null,"Model-66","MTF1",-0.09989]
[null,"Model-66","CDKN2A",{"v":-0.0142,"d":"-0.01420"}]
[null,"Model-66","DBT",0.02607]
[null,"Model-66","DLST",0.00519]
["A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma","Model-67","ADAM12",{"v":3.278811,"d":"3.27881"}]
[null,"Model-67","C1QL1",{"v":3.418479,"d":"3.41848"}]
[null,"Model-67","CYP4F12",{"v":0.820077,"d":"0.82008"}]
[null,"Model-67","FOXI3",5.72035]
[null,"Model-67","HBD",{"v":3.853467,"d":"3.85347"}]
[null,"Model-67","SPDYC",{"v":3.454219,"d":"3.45422"}]
[null,"Model-67","SRD5A2",{"v":3.549356,"d":"3.54936"}]
["m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma","Model-68","CYP26A10",{"v":0.178,"d":"0.17800"}]
[null,"Model-68","KIF13B ",{"v":0.446,"d":"0.44600"}]
[null,"Model-68","CPVL",{"v":0.305,"d":"0.30500"}]
[null,"Model-68","FCGBP",{"v":0.238,"d":"0.23800"}]
[null,"Model-68","MB",{"v":0.087,"d":"0.08700"}]
["Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma","Model-69","AJAP1",{"v":-0.155,"d":"-0.15500"}]
[null,"Model-69","SHANK2",{"v":0.089,"d":"0.08900"}]
[null,"Model-69","FOXA2",{"v":0.147,"d":"0.14700"}]
[null,"Model-69","MT1A ",{"v":0.111,"d":"0.11100"}]
[null,"Model-69","ZNF570",{"v":-0.173,"d":"-0.17300"}]
[null,"Model-69","HOXC4",{"v":0.03,"d":"0.03000"}]
[null,"Model-69","HOXB4",{"v":0.789,"d":"0.78900"}]
["Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma","Model-70","TTLL1",{"v":-0.340762078142984,"d":"-0.34076"}]
[null,"Model-70","TRIML2",{"v":0.155856436328617,"d":"0.15586"}]
[null,"Model-70","DYNC1I1",{"v":0.354422850701632,"d":"0.35442"}]
[null,"Model-70","KLHL35",{"v":-0.0188085307934091,"d":"-0.01881"}]
[null,"Model-70","CAMK2N1",{"v":0.125069305655967,"d":"0.12507"}]
[null,"Model-70","TNFRSF18",{"v":-0.120601015006529,"d":"-0.12060"}]
[null,"Model-70","GLDC",{"v":0.074952752875697,"d":"0.07495"}]
[null,"Model-70","SPINK5",{"v":-0.056890030222726,"d":"-0.05689"}]
[null,"Model-70","DKK1",{"v":0.0811360667781742,"d":"0.08114"}]
["Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma","Model-71","CXCL9",{"v":-0.167234250970157,"d":"-0.16723"}]
[null,"Model-71","CXCL10",{"v":0.0773667110295684,"d":"0.07737"}]
[null,"Model-71","IDO1",{"v":-0.109165507024822,"d":"-0.10917"}]
[null,"Model-71","IFNG",{"v":0.0260086277228177,"d":"0.02601"}]
[null,"Model-71","HLA-DRA",{"v":0.00615535094101843,"d":"0.00616"}]
[null,"Model-71","STAT1",{"v":0.226517384369527,"d":"0.22652"}]
["A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer","Model-72","NCEH1",{"v":0.00375648778580829,"d":"0.00376"}]
[null,"Model-72","DDIT4",{"v":0.000196895217642536,"d":"0.00020"}]
[null,"Model-72","ITGB4",{"v":0.000182340335661025,"d":"0.00018"}]
[null,"Model-72","FADD",{"v":0.00295710608145753,"d":"0.00296"}]
[null,"Model-72","TIMP1",{"v":0.000265155619051945,"d":"0.00027"}]
["Investigation of an FGFR-Signaling-Related Prognostic Model and Immune Landscape in Head and Neck Squamous Cell Carcinoma","Model-73","AREG",{"v":0.0369,"d":"0.03690"}]
[null,"Model-73","THBS1",0.03432]
[null,"Model-73","SEMA3C",0.02182]
[null,"Model-73","ANO1",0.07125]
[null,"Model-73","IGHG2",-0.07718]
[null,"Model-73","EPHX3",-0.09177]
["Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma","Model-74","GTSE1",{"v":0.000120172645339832,"d":"0.00012"}]
[null,"Model-74","LRRN4CL",{"v":-0.0528500133738702,"d":"-0.05285"}]
[null,"Model-74","CRYAB",{"v":0.000762605813980582,"d":"0.00076"}]
[null,"Model-74","SHOX2",{"v":-0.0375869917055289,"d":"-0.03759"}]
[null,"Model-74","ASNS",{"v":0.00793013960031362,"d":"0.00793"}]
[null,"Model-74","KRT23",{"v":0.000861879077808672,"d":"0.00086"}]
[null,"Model-74","ANGPT2",{"v":0.00352929616704944,"d":"0.00353"}]
[null,"Model-74","HOXA9",{"v":0.0103389677539615,"d":"0.01034"}]
[null,"Model-74","CARD11",{"v":-0.00233006727253382,"d":"-0.00233"}]
["A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma","Model-75","FTH1",{"v":0.000313944270511738,"d":"0.00031"}]
[null,"Model-75","BNIP3",{"v":0.00699420793641565,"d":"0.00699"}]
[null,"Model-75","TRIB3",{"v":0.00666533246355529,"d":"0.00667"}]
[null,"Model-75","SLC2A3",{"v":0.00369703183332897,"d":"0.00370"}]
["A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma","Model-76","HEXB",0.01247]
[null,"Model-76","ACAT1",0.01996]
[null,"Model-76","GNPDA1",0.02995]
[null,"Model-76","POLE2",-0.17051]
[null,"Model-76","SMS",0.00156]
[null,"Model-76","AGPS",{"v":0.0005,"d":"0.00050"}]
[null,"Model-76","PYGL",0.00442]
[null,"Model-76","ACAA1",-0.00201]
[null,"Model-76","MTHFD2",0.00689]
[null,"Model-76","PLCB3",0.02056]
[null,"Model-76","POLD2",{"v":0.0017,"d":"0.00170"}]
[null,"Model-76","KYNU",0.03766]
[null,"Model-76","ENTPD1",-0.01556]
[null,"Model-76","LCLAT1",0.02843]
[null,"Model-76","PIP4K2A",-0.00409]
[null,"Model-76","DNMT1",-0.01837]
[null,"Model-76","ADK",0.00435]
[null,"Model-76","ADA",{"v":0.0148,"d":"0.01480"}]
[null,"Model-76","PAFAH1B2",0.00517]
[null,"Model-76","PLA2G2D",-0.03567]
[null,"Model-76","DGKQ",-0.03222]
[null,"Model-76","ADH7",0.00527]
[null,"Model-76","ACOX3",-0.00481]
[null,"Model-76","ASNS",0.00862]
[null,"Model-76","HPRT1",0.00982]
[null,"Model-76","ATIC",0.00835]
[null,"Model-76","PRPS1",0.01487]
[null,"Model-76","NADSYN1",0.01067]
["A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma","Model-77","ADM",{"v":0.324,"d":"0.32400"}]
[null,"Model-77","CYSLTR1",{"v":-0.379,"d":"-0.37900"}]
[null,"Model-77","DDIT4",{"v":0.353,"d":"0.35300"}]
[null,"Model-77","DOCK8",{"v":-0.326,"d":"-0.32600"}]
[null,"Model-77","ENO2",{"v":0.29,"d":"0.29000"}]
[null,"Model-77","FCER1A",{"v":-0.28,"d":"-0.28000"}]
[null,"Model-77","IL17A","-0.286"]
[null,"Model-77","IZUMO4",{"v":-0.328,"d":"-0.32800"}]
[null,"Model-77","MMP25",{"v":-0.273,"d":"-0.27300"}]
[null,"Model-77","P2RY14",{"v":-0.362,"d":"-0.36200"}]
[null,"Model-77","RBP4",{"v":0.292,"d":"0.29200"}]
[null,"Model-77","ZNF252P-AS1",{"v":-0.299,"d":"-0.29900"}]
["Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy","Model-78","SERPINE1",{"v":-0.319322778,"d":"-0.31932"}]
[null,"Model-78","INHBA",{"v":-0.417843642,"d":"-0.41784"}]
[null,"Model-78","ACTN1",{"v":0.24520493,"d":"0.24520"}]
[null,"Model-78","P4HA2",{"v":0.709588827,"d":"0.70959"}]
[null,"Model-78","CD24",{"v":0.477760262,"d":"0.47776"}]
[null,"Model-78","TCF3",{"v":-0.25962002,"d":"-0.25962"}]
[null,"Model-78","HILPDA",{"v":-0.453322755,"d":"-0.45332"}]
["Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset","Model-79","POU4F1",{"v":0.0591552026238837,"d":"0.05916"}]
[null,"Model-79","IL34",{"v":-0.0118712931878421,"d":"-0.01187"}]
[null,"Model-79","HLF",{"v":-0.0116733604179202,"d":"-0.01167"}]
[null,"Model-79","CBS",{"v":0.060209314077905,"d":"0.06021"}]
[null,"Model-79","RNF165",{"v":-0.0311922376319244,"d":"-0.03119"}]
["A Tumor-Infiltration CD8+ T Cell-Based Gene Signature for Facilitating the Prognosis and Estimation of Immunization Responses in HPV+ Head and Neck Squamous Cell Cancer","Model-80","ACAP1",{"v":-0.0507629039982876,"d":"-0.05076"}]
[null,"Model-80","ANKRD28",{"v":-0.031044654098992,"d":"-0.03104"}]
[null,"Model-80","C12orf75",{"v":0.000919233214222203,"d":"0.00092"}]
[null,"Model-80","M6PR",{"v":0.00417293946537411,"d":"0.00417"}]
["Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma","Model-81","EGFR",0.09646]
[null,"Model-81","FADD",0.18189]
[null,"Model-81","PARK2",0.52452]
["Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma","Model-82","TNFRSF13B",{"v":-0.288401925578821,"d":"-0.28840"}]
[null,"Model-82","TNFRSF13C",{"v":0.0298599827750141,"d":"0.02986"}]
[null,"Model-82","TNFRSF14",{"v":0.022444681038869,"d":"0.02244"}]
[null,"Model-82","TNFRSF19",{"v":-0.00770631939492358,"d":"-0.00771"}]
[null,"Model-82","TNFRSF18",{"v":-0.00191601064008742,"d":"-0.00192"}]
[null,"Model-82","TNFRSF25",{"v":-0.0353600496917108,"d":"-0.03536"}]
[null,"Model-82","ICOS",{"v":-0.0563225590958169,"d":"-0.05632"}]
[null,"Model-82","EDA",{"v":0.102751139435638,"d":"0.10275"}]
[null,"Model-82","TNFRSF12A",{"v":0.00206060715073606,"d":"0.00206"}]
["Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature","Model-83","BAK1",{"v":0.00252709466730682,"d":"0.00253"}]
[null,"Model-83","GSDME",{"v":0.00765287644485668,"d":"0.00765"}]
[null,"Model-83","IL1A",{"v":0.000527033458381314,"d":"0.00053"}]
[null,"Model-83","CHMP7",{"v":-0.00303660861796722,"d":"-0.00304"}]
[null,"Model-83","NLRP1",{"v":-0.0249665998447706,"d":"-0.02497"}]
[null,"Model-83","GZMB",{"v":-0.00546104577993706,"d":"-0.00546"}]
["Identification and clinical validation of gene signatures with grade and survival in head and neck carcinomas","Model-84","CXCL14",{"v":5.728,"d":"5.72800"}]
[null,"Model-84","SLC44A1",{"v":-21.232,"d":"-21.23200"}]
[null,"Model-84","UBD",{"v":-2.036,"d":"-2.03600"}]
[null,"Model-84","PPP2R2C",{"v":4.559,"d":"4.55900"}]
[null,"Model-84","SLC44A1",{"v":-25.517,"d":"-25.51700"}]